The FDA announced today that, in conjunction with the American Society of Plastic Surgery and the American Society of Aesthetic Plastic Surgery, it has been following a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), an extremely rare type of lymphoma.
Click here to read detailed patient safety information from the American Society of Plastic Surgeons.
Breast implant associated-ALCL (BIA-ALCL) is a distinct entity from other types of ALCL. It is a very rare and treatable type of lymphoma that can develop around breast implants. Lymphoma is a cancer of immune cells; BIA-ALCL is not a breast cancer. BIA-ALCL is easily treatable in almost all cases.
I have been up-to-date on the published literature as it has been released and will continue to monitor any new develops on this and any other topic related to our services.
Whether you are interested in breast augmentation surgery or have existing implants, if you have concerns or questions, please schedule a consultation with me. My only goal is to help you make the best decision for yourself.
Lawrence Iteld, MD
Certified, American Board of Plastic Surgery